Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of SID142 in Healthy Volunteers
NCT02625714Phase 1Completed
- Sponsor
- SK Chemicals
- Start
- Jun 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of cilostazol + ginkgo leaf extract in arterial occlusive disease (AOD) (2 arms), sponsored by SK Chemicals. Primary endpoints: Area under the concentration curve at steady state over a dosing interval and Maximum plasma concentration at steady state. Started Jun 2015; status: completed.
02
Drugs
cilostazol + ginkgo leaf extract
03
Conditions
arterial occlusive disease (AOD)
Beyond the preview
Go deeper on NCT02625714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02625714.